Dow Up 0.51% Nasdaq Up 0.24%

Agios Pharmaceuticals, Inc. (AGIO)

-NasdaqGS
94.84 1.83(1.97%) Nov 21, 4:00PM EST
|After Hours : 94.75 Down 0.09 (0.09%) Nov 21, 7:59PM EST
Prev Close:93.01
Open:94.30
Bid:92.75 x 200
Ask:N/A
1y Target Est:92.80
Beta:1.979
Next Earnings Date:N/A
Day's Range:92.71 - 97.36
52wk Range:15.91 - 99.71
Volume:722,067
Avg Vol (3m):758,712
Market Cap:3.29B
P/E (ttm):N/A
EPS (ttm):-1.20
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AGIOUp 1.97%3.29B
ALXN37.88B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):56.14
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.42
Quarterly EPS Est (Dec-14) :-0.61
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Agios Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics in the field of cancer metabolism and inborn errors of metabolism (IEMs) in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback